Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense, 6222 [2020-02087]

Download as PDF 6222 Federal Register / Vol. 85, No. 23 / Tuesday, February 4, 2020 / Notices DEPARTMENT OF JUSTICE Antitrust Division [OMB Number: 1105–New] Agency Information Collection Activities: New Information Collection; Comment Request Antitrust Division, Department of Justice. AGENCY: 30-Day notice of new information collection and request for comments; Procurement Collusion Strike Force complaint form. ACTION: The Department of Justice, Antitrust Division, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. SUMMARY: The Department of Justice encourages public comment and will accept input until March 5, 2020. Written comments on the proposed information collection should be submitted to the Office of Management and Budget, Office of Information and Regulatory Affairs. Comments should be addressed to the OMB Desk Officer for the Department of Justice, and sent to OIRA_submissions@omb.eop.gov. DATES: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information should address one or more of the following four points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Department of Justice, Antitrust Division, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. khammond on DSKJM1Z7X2PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:48 Feb 03, 2020 Jkt 250001 Overview of This Information Collection (1) Type of Information Collection: New information collection. (2) The Title of the Form/Collection: Procurement Collusion Strike Force Complaint Form. (3) The agency form number, if any, and the applicable component of the Department sponsoring the collection: The applicable component within the Department of Justice is the Antitrust Division. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary respondents will be individuals or households. The Procurement Collusion Strike Force (PCSF) complaint form facilitates reporting by the public of complaints, concerns, and tips regarding potential antitrust crimes affecting government procurement, grants, and program funding. Respondents will be able to complete and submit information electronically through the PCSF complaint form on the Antitrust Division’s website. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: 500 respondents annually and 30 minutes for an individual to respond. (6) An estimate of the total public burden (in hours) associated with the collection: 250 annual burden hours. If additional information is required contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, 3E.405A, Washington, DC 20530. Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, CFD Research Corporation; Huntsville, AL; GattaCo, Inc.; Murrieta, CA; George Mason University; Fairfax, VA; Nutra Pharma Corporation; Coral Springs, FL, have been added as a party to this venture. Also, Achaogen, Inc.; San Francisco, CA; Adapt Pharma, Inc.; Radnor, PA; Certara USA; Princeton, NJ; Colorado State University; Fort Collins, CO; Creare, LLC; Hanover, NH; GigaGen, Inc.; San Francisco, CA; Inflammatix, Inc.; Burlingame, CA; Lynntech; College Station, TX; Nano Terra, Inc.; Cambridge, MA; Prosolia, Inc.; Indianapolis, IN; Southern Research Institute; Birmingham, AL; and Spero Therapeutics, Inc.; Cambridge, MA have withdrawn as parties from this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open and MCDC intends to file additional written notifications disclosing all changes in membership. On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513). The last notification was filed with the Department on October 24, 2019. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on November 25, 2019 (84 FR 64923). Dated: January 30, 2020. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2020–02142 Filed 2–3–20; 8:45 am] [FR Doc. 2020–02087 Filed 2–3–20; 8:45 am] BILLING CODE 4410–BA–P BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Antitrust Division Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical CBRN Defense Notice Pursuant to the National Cooperative Research and Production Act of 1993—Open Source Imaging Notice is hereby given that, on January 16, 2020, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical CBRN Defense Consortium (‘‘MCDC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Notice is hereby given that, on January 14, 2020, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Open Source Imaging Consortium, Inc. (‘‘OSI’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 E:\FR\FM\04FEN1.SGM 04FEN1

Agencies

[Federal Register Volume 85, Number 23 (Tuesday, February 4, 2020)]
[Notices]
[Page 6222]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02087]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense

    Notice is hereby given that, on January 16, 2020, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense 
Consortium (``MCDC'') has filed written notifications simultaneously 
with the Attorney General and the Federal Trade Commission disclosing 
changes in its membership. The notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, CFD Research Corporation; Huntsville, AL; GattaCo, Inc.; 
Murrieta, CA; George Mason University; Fairfax, VA; Nutra Pharma 
Corporation; Coral Springs, FL, have been added as a party to this 
venture.
    Also, Achaogen, Inc.; San Francisco, CA; Adapt Pharma, Inc.; 
Radnor, PA; Certara USA; Princeton, NJ; Colorado State University; Fort 
Collins, CO; Creare, LLC; Hanover, NH; GigaGen, Inc.; San Francisco, 
CA; Inflammatix, Inc.; Burlingame, CA; Lynntech; College Station, TX; 
Nano Terra, Inc.; Cambridge, MA; Prosolia, Inc.; Indianapolis, IN; 
Southern Research Institute; Birmingham, AL; and Spero Therapeutics, 
Inc.; Cambridge, MA have withdrawn as parties from this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open and MCDC intends to file additional 
written notifications disclosing all changes in membership.
    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on October 24, 
2019. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on November 25, 2019 (84 FR 64923).

Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2020-02087 Filed 2-3-20; 8:45 am]
 BILLING CODE 4410-11-P